Jacobs Levy Equity Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-19,300
| Closed | -$266K | – | 1131 |
|
|
2018
Q2 | $266K | Hold |
19,300
| – | – | ﹤0.01% | 909 |
|
|
2018
Q1 | $175K | Sell |
19,300
-87,341
| -82% | -$792K | ﹤0.01% | 943 |
|
|
2017
Q4 | $456K | Buy |
106,641
+77,600
| +267% | +$332K | 0.01% | 771 |
|
|
2017
Q3 | $41K | Sell |
29,041
-112,731
| -80% | -$159K | ﹤0.01% | 933 |
|
|
2017
Q2 | $213K | Buy |
141,772
+113,145
| +395% | +$170K | ﹤0.01% | 826 |
|
|
2017
Q1 | $74K | Sell |
28,627
-47,747
| -63% | -$123K | ﹤0.01% | 880 |
|
|
2016
Q4 | $195K | Buy |
76,374
+26,620
| +54% | +$68K | ﹤0.01% | 838 |
|
|
2016
Q3 | $154K | Sell |
49,754
-17,739
| -26% | -$54.9K | ﹤0.01% | 935 |
|
|
2016
Q2 | $217K | Buy |
+67,493
| New | +$217K | ﹤0.01% | 991 |
|
|
2015
Q1 | – | Sell |
-36,400
| Closed | -$229K | – | 927 |
|
|
2014
Q4 | $229K | Buy |
+36,400
| New | +$229K | ﹤0.01% | 722 |
|